Choose the experimental features you want to try

This document is an excerpt from the EUR-Lex website

Document 22011D0014

    Decision of the EEA Joint Committee No 14/2011 of 1 April 2011 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement

    IO L 171, 30.6.2011, p. 11–12 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

    Foilsíodh an doiciméad seo in eagrán speisialta (HR)

    Legal status of the document In force

    ELI: http://data.europa.eu/eli/dec/2011/14(2)/oj

    30.6.2011   

    EN

    Official Journal of the European Union

    L 171/11


    DECISION OF THE EEA JOINT COMMITTEE

    No 14/2011

    of 1 April 2011

    amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement

    THE EEA JOINT COMMITTEE,

    Having regard to the Agreement on the European Economic Area, as amended by the Protocol adjusting the Agreement on the European Economic Area, hereinafter referred to as ‘the Agreement’, and in particular Article 98 thereof,

    Whereas:

    (1)

    Annex II to the Agreement was amended by Decision of the EEA Joint Committee No 128/2010 of 10 December 2010 (1).

    (2)

    Commission Directive 2010/5/EU of 8 February 2010 amending Directive 98/8/EC of the European Parliament and of the Council to include acrolein as an active substance in Annex I thereto (2) is to be incorporated into the Agreement.

    (3)

    Commission Directive 2010/8/EU of 9 February 2010 amending Directive 98/8/EC of the European Parliament and of the Council to include warfarin sodium as an active substance in Annex I thereto (3) is to be incorporated into the Agreement.

    (4)

    Commission Directive 2010/9/EU of 9 February 2010 amending Directive 98/8/EC of the European Parliament and of the Council to extend the inclusion in Annex I thereto of the active substance aluminium phosphide releasing phosphine to product type 18 as defined in Annex V thereto (4) is to be incorporated into the Agreement.

    (5)

    Commission Directive 2010/10/EU of 9 February 2010 amending Directive 98/8/EC of the European Parliament and of the Council to include brodifacoum as an active substance in Annex I thereto (5) is to be incorporated into the Agreement.

    (6)

    Commission Directive 2010/11/EU of 9 February 2010 amending Directive 98/8/EC of the European Parliament and of the Council to include warfarin as an active substance in Annex I thereto (6) is to be incorporated into the Agreement.

    (7)

    Commission Decision 2010/122/EU of 25 February 2010 amending, for the purposes of adapting to scientific and technical progress, the Annex to Directive 2002/95/EC of the European Parliament and of the Council as regards an exemption for an application of cadmium (7) is to be incorporated into the Agreement,

    HAS DECIDED AS FOLLOWS:

    Article 1

    Chapter XV of Annex II to the Agreement shall be amended as follows:

    (1)

    the following indents shall be added in point 12n (Directive 98/8/EC of the European Parliament and of the Council):

    ‘—

    32010 L 0005: Commission Directive 2010/5/EU of 8 February 2010 (OJ L 36, 9.2.2010, p. 24),

    32010 L 0008: Commission Directive 2010/8/EU of 9 February 2010 (OJ L 37, 10.2.2010, p. 37),

    32010 L 0009: Commission Directive 2010/9/EU of 9 February 2010 (OJ L 37, 10.2.2010, p. 40),

    32010 L 0010: Commission Directive 2010/10/EU of 9 February 2010 (OJ L 37, 10.2.2010, p. 44),

    32010 L 0011: Commission Directive 2010/11/EU of 9 February 2010 (OJ L 37, 10.2.2010, p. 47).’;

    (2)

    the following indent shall be added in point 12q (Directive 2002/95/EC of the European Parliament and of the Council):

    ‘—

    32010 D 0122: Commission Decision 2010/122/EU of 25 February 2010 (OJ L 49, 26.2.2010, p. 32).’.

    Article 2

    The texts of Directives 2010/5/EU, 2010/8/EU, 2010/9/EU, 2010/10/EU, 2010/11/EU and Decision 2010/122/EU in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.

    Article 3

    This Decision shall enter into force on 2 April 2011, provided that all the notifications under Article 103(1) of the Agreement have been made to the EEA Joint Committee (*1).

    Article 4

    This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.

    Done at Brussels, 1 April 2011.

    For the EEA Joint Committee

    The Acting President

    Gianluca GRIPPA


    (1)   OJ L 85, 31.3.2011, p. 11.

    (2)   OJ L 36, 9.2.2010, p. 24.

    (3)   OJ L 37, 10.2.2010, p. 37.

    (4)   OJ L 37, 10.2.2010, p. 40.

    (5)   OJ L 37, 10.2.2010, p. 44.

    (6)   OJ L 37, 10.2.2010, p. 47.

    (7)   OJ L 49, 26.2.2010, p. 32.

    (*1)  No constitutional requirements indicated.


    Top